Trader’s Buzz: Alexion Pharmaceuticals (ALXN), Moneygram (MGI), Fate Therapeutics (FATE), PlasmaTech (PTBI)

Shares of Synageva BioPharma Corp. (GEVA) are surging $119, or 125%, to $215.16 in early trading on Wednesday after the company announced its $8.4-billion acquisition by Alexion Pharmaceuticals (ALXN). Alexion said it will pay $115 in cash and a portion of its stock for each Synageva share. That puts the total per-share price at $230 […] View the full post at: Trader’s Buzz: Alexion Pharmaceuticals (ALXN), Moneygram (MGI), Fate Therapeutics (FATE), PlasmaTech (PTBI) Related posts: Cramer: Medicis Pharmaceuticals Looks Attractive Walt Disney to Acquire Marvel Entertainment for $4B Russian Tech Group Offers to Invest $200 mln in Facebook